Scleroderma Research - CA San Francisco, San Francisco 94104

Scleroderma Research entered the industry of Medical Research in 1987 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417200, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Deann Wright, President by calling (415) 834-9444 during business hours. You can also write to the business’ Single Location at 220 Montgomery St # 1411, San Francisco, California CA 94104. You can also visit the company’s website at sclerodermaresearch.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: Scleroderma Research
Representative: Deann Wright, President
Place of Business: 220 Montgomery St # 1411, San Francisco, CA 94104
Contact Number: (415) 834-9444
Website: sclerodermaresearch.org
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 5417200
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1987
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Scleroderma Research is a company operating from San Francisco, California providing professional Medical Research and relevant B2B variables. It was founded in 1987 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417200 as Medical Research.

With a current employee count of 1 to 4, Scleroderma Research has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Deann Wright, President at (415) 834-9444 for related queries, or to locate its Single Location using the coordinates 37.791188,-122.402355.

The Single Location can also be found at the street address 220 Montgomery St # 1411 in San Francisco, California 94104 and can be engaged online through the company website at sclerodermaresearch.org, the company Twitter , and Facebook page .